866-997-4948(US-Canada Toll Free)

Ovarian Cancer Global Clinical Trials Review, Q4, 2010

Published By :

GlobalData

Published Date : Nov 2010

Category :

Ovarian Cancer

No. of Pages : 70 Pages

 

 

GlobalData's clinical trial report, “Ovarian Cancer Global Clinical Trials Review, Q4, 2010""” provides data on the Ovarian Cancer clinical trial scenario. This report provides in-depth information and data relating to the clinical trials on Ovarian Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial development throughout the world, focusing on the status of participation by the developing nations. It offers coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides information pertaining to the number of trials for the key drugs for treating Ovarian Cancer. 

 

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts. 

 

Scope

 

  • Data on the number of clinical trials conducted in North America, South And Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status and trial success rate
  • Review of key discontinued trials (suspended, withdrawn and terminated)
  • Overview of the enrollment pattern by phase for the past decade
  • Number of clinical trials segmented by key drugs
  • Clinical trial overview of top 20 companies, which include Pfizer Inc., AstraZeneca PLC, Eli Lilly and Company, and so on.
  • Clinical trial overview of top 20 Universities / Institutes / Hospitals including National Cancer Institute, Cancer Research UK, Cancer Research Institute , and others

Reasons to buy

 

  • Understand the dynamics of a particular indication as a whole
  • Examine the performance of the trials in terms of their status, recruitment, success rates and others
  • Obtain discontinued trial information for trials across the globe
  • Understand the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

1 Table of Contents

1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 5

2 Introduction 6
2.1 Ovarian Cancer Overview 6
2.2 Report Guidance 6

3 Clinical Trials by Region 7
3.1 Clinical Trials by Country 8
3.1.1 Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
3.1.2 Top Five Countries Contributing to Clinical Trials in Europe 11
3.1.3 Top Countries Contributing to Clinical Trials in North America 12
3.1.4 Top Countries Contributing to Clinical Trials in Middle East and Africa. 13
3.1.5 Top Countries Contributing to Clinical Trials in Central and South America 14
3.2 Clinical Trials by BRIC Countries 15

4 Clinical Trials by Phase 16
4.1 In Progress Trials by Phase 17

5 Clinical Trials by Trial Status 18

6 Unaccomplished Trials of Ovarian Cancer 20

7 Subjects Recruited Over a Period of Time 25

8 Prominent Sponsors 26

8.1 Top Companies Participating in Ovarian cancer Therapeutics Clinical Trials 27

9 Prominent Drug Comparison 28

10 Clinical Trial Profiles 29

10.1 Clinical Trial Overview of Top 10 Companies 29
10.1.1 Eli Lilly and Company 29
10.1.2 AstraZeneca 30
10.1.3 Merck & Co., Inc 31
10.1.4 Sanofi-Aventis 32
10.1.5 F. Hoffmann-La Roche Ltd. 33
10.1.6 GlaxoSmithKline PLC 34
10.1.7 Eisai Co., Ltd. 35
10.1.8 Johnson & Johnson 36
10.1.9 Amgen Inc. 37
10.1.10 Takeda Pharmaceutical Company Limited 38
10.2 Clinical Trial Overview by Top 10 Universities / Institutes / Hospitals 38
10.2.1 National Cancer Center (NCI) 38
10.2.2 Memorial Sloan Kettering Center 50
10.2.3 Gynaecologic Oncology Group 54
10.2.4 The University of Texas M.D. Anderson Cancer Center 57
10.2.5 Fred Hutchinson Cancer Research Center-Technology Transfer 60
10.2.6 European Organization for Research and Treatment of Cancer 62
10.2.7 AGO Cancer Study Group 63
10.2.8 Cancer Research UK 64
10.2.9 Dana-Farber Cancer Institute 65
10.2.10 Masonic Cancer Center 66

11 Appendix 67
11.1 Abbreviations 67
11.2 Definitions 67
11.3 Research Methodology 68
11.4 Secondary Research 69
11.5 About GlobalData 69
11.6 Contact Us 69
11.7 Disclaimer 70
11.8 Source 70

List of Table


Table 1: Ovarian Cancer Therapeutics Market, Global, Clinical Trials by Zone (%), 2010* 7
Table 2: Ovarian cancer Clinical Trials In Progress by Top Countries, 1982-2010* 9
Table 3: Ovarian cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2010* 10
Table 4: Ovarian cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2010* 11
Table 5: Ovarian cancer Therapeutics Clinical Trials, North America, Top Five Countries, 2010* 12
Table 6: Ovarian cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2010* 13
Table 7: Ovarian cancer Therapeutics Clinical Trials, Central and South America, Top Countries, 2010* 14
Table 8: Ovarian Cancer Therapeutics Clinical Trials, BRIC Countries, 2010* 15
Table 9: Ovarian cancer Therapeutics Market, Global, Clinical Trials by Phase, 2010* 16
Table 10: Ovarian cancer Therapeutics Market, Global, Clinical Trials in Progress by Phase, 2010* 17
Table 11: Ovarian cancer Therapeutics Market, Global, Clinical Trials by Trial Status, 2010* 19
Table 12: Ovarian cancer Therapeutics Market, Global, Suspended Clinical Trials, 2010* 20
Table 13: Ovarian cancer Therapeutics Market, Global, Terminated Clinical Trials, 2010* 21
Table 14: Ovarian cancer Therapeutics Market, Global, Withdrawn Clinical Trials, 2010* 24
Table 15: Ovarian Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2009 25
Table 16: Ovarian cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2010* 26
Table 17: Ovarian Cancer Therapeutics Clinical Trials, Global, Enrollment Target Trends by Phase and Year, 2005-2010* 27
Table 18: Ovarian Cancer Therapeutics Clinical Trials, Global, Clinical Trials in Progress by Prominent Drugs, 2010* 28
Table 19: Ovarian cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2010* 29
Table 20: Ovarian cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Astra-Zeneca PLC, 2010* 30
Table 21: Ovarian cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc. 2010* 31
Table 22: Ovarian cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi-Aventis, 2010* 32
Table 23: Ovarian cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2010* 33
Table 24: Ovarian cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline PLC, 2010* 34
Table 25: Ovarian cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Co., Ltd., 2010* 35
Table 26: Ovarian cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2010* 36
Table 27: Ovarian cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2010* 37
Table 28: Ovarian cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 2010* 38
Table 29: Ovarian Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Center, 2010* 39
Table 30: Ovarian Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2010* 51
Table 31: Ovarian Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Gynaecologic Oncology Group, 2010* 55
Table 32: Ovarian Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2010* 58
Table 33: Ovarian Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred Hutchinson Cancer Research Center-Technology Transfer, 2010* 61
Table 34: Ovarian Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by European Organization for Research and Treatment of Cancer, 2010* 62
Table 35: Ovarian Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by AGO Ovarian Cancer Study Group, 2010* 63
Table 36: Ovarian Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Cancer Research UK,, 2010* 64
Table 37: Ovarian Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Dana-Farber Cancer Institute, 2010* 65
Table 38: Ovarian Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Masonic Cancer Center, 2010* 66

List of Chart


Figure 1: Ovarian Cancer Therapeutics Market, Global, Clinical Trials by Zone (%), 2010* 7
Figure 2: Ovarian cancer Therapeutics Market, Global, Clinical Trials by Top Countries, 2010* 8
Figure 3: Ovarian cancer Therapeutics Market, Global, Clinical Trials in Progress by Top Countries, 2010* 9
Figure 4: Ovarian cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2010* 10
Figure 5: Ovarian cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2010* 11
Figure 6: Ovarian cancer Therapeutics Clinical Trials, North America, Top Five Countries (%), 2010* 12
Figure 7: Ovarian cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2010* 13
Figure 8: Ovarian cancer Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2010* 14
Figure 9: Ovarian cancer Therapeutics Clinical Trials, BRIC Countries (%), 2010* 15
Figure 10: Ovarian cancer Therapeutics Market, Global, Clinical Trials by Phase (%), 2010* 16
Figure 11: Ovarian cancer Therapeutics Market, Global, Clinical Trials in Progress by Phase, 2010* 17
Figure 12: Ovarian cancer Therapeutics Market, Global, Clinical Trials by Trial Status, 2010* 18
Figure 13: Ovarian Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2009 25
Figure 14: Ovarian cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2010* 26
Figure 15: Ovarian cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2010* 27
Figure 16: Ovarian Cancer Clinical Trials by Prominent Drugs, 1982-2010* 28
Figure 17: GlobalData Methodology 68

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *